Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3372840 | 0.84 | ROCK2 (0.50) | ROCK2MTNR1AMTNR1BKCNH2KDM4E | |
| SCHEMBL3372837 | 0.84 | ROCK2 (0.50) | ROCK2MTNR1AMTNR1BKCNH2KDM4E | |
| SCHEMBL3452803 | 0.84 | ROCK2 (0.50) | ROCK2MTNR1AMTNR1BKCNH2KDM4E | |
| SCHEMBL3452807 | 0.84 | ROCK2 (0.50) | ROCK2MTNR1AMTNR1BKCNH2KDM4E | |
| SCHEMBL2328590 | 0.81 | MTNR1A (0.42) | ROCK2MTNR1AMTNR1BKCNH2KDM4E | |
| SCHEMBL2325491 | 0.81 | MTNR1A (0.42) | ROCK2MTNR1AMTNR1BKCNH2KDM4E | |
| SCHEMBL2504913 | 0.80 | KCNH2 (0.42) | KCNH2 | |
| SCHEMBL5525352 | 0.80 | KCNH2 (0.42) | KCNH2 | |
| SCHEMBL11930642 | 0.77 | KCNH2 (0.68) | KCNH2 | |
| SCHEMBL5506988 | 0.76 | KDM4E (0.44) | ROCK2MTNR1AMTNR1BKCNH2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1799676-A2 | NEW BICYCLIC ANTIBIOTICS | Actelion Pharmaceuticals Ltd. (CH) | 2007-06-27 | — | — | EP | disclosed |
| WO-2006032466-A2 | NEW BICYCLIC ANTIBIOTICS | ACTELION PHARMACEUTICALS LTD (CH) | 2006-03-30 | — | — | WO | disclosed |